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To investigate mechanisms conferring susceptibility or
resistance to renal ischemia, we used two rat strains known
to exhibit different responses to ischemia–reperfusion. We
exposed proximal tubule cells isolated from Sprague Dawley
or Brown Norway rats, to a protocol of hypoxia, followed by
reoxygenation in vitro. The cells isolated from both rat strains
exhibited comparable responses in the disruption of
intercellular adhesions and cytoskeletal damage. In vivo, after
24h of reperfusion, both strains showed similar degrees of
injury. However, after 7 days of reperfusion, renal function
and tubular structure almost completely recovered and
inflammation resolved, but only in Brown Norway rats.
Hypoxia-inducible factor-dependent gene expression,
ERK1/2, and Akt activation were different in the two strains.
Inflammatory mediators MCP-1, IL-10, INF-c, IL-1b, and TNF-a
were similarly induced at 24h in both strains but were
downregulated earlier in Brown Norway rats, which
correlated with shorter NFjB activation in the kidney.
Moreover, VLA-4 expression in peripheral blood lymphocytes
and VCAM-1 expression in kidney tissues were initially similar
at 24h but reached basal levels earlier in Brown Norway rats.
The faster resolution of inflammation in Brown Norway rats
suggests that this strain might be a useful experimental
model to determine the mechanisms that promote repair of
renal ischemia–reperfusion injury.
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Acute tubular necrosis (ATN) due to ischemia–reperfusion
(I/R) is observed in important clinical settings, such as patients
in intensive care units and those undergoing kidney transplan-
tation.1 In this situation, ATN contributes to most cases of
delayed graft function, is related to higher immunogenicity and
is a predictive factor for poor allograft outcome.2
ATN is characterized by proximal epithelial cell shedding,
cell death inflammation in renal parenchyma and kidney
dysfunction.3 Mechanisms responsible for ATN development
have been identified by experimental models, such as the
widely used 45-min of bilateral renal ischemia in rats. In this
model, analogous to humans, moderate damage occurring
mainly in the proximal tubules and recovery after some days
of reperfusion were observed.4 In vitro models have also shed
light on the mechanisms underlying proximal tubule cell
response to ischemia.5 However, in spite of the advances in
experimental models, not much progress has reached clinical
practice.
Genetically modified animals could be used to identify
new targets to improve ATN outcome. Unfortunately, genetic
modification in rats is difficult. Therefore, some rat strains
have been selected for their different response or suscept-
ibility to ischemia. Indeed, some reports have identified
inbred Brown Norway rats as more resistant to cardiac
ischemia than other rat strains,6,7 including the outbred
Sprague Dawley rats. Resistance to the development of
tubular damage after renal ischemia was also described in
Brown Norway rats.8,9 These reports indicated higher levels
of heat-shock proteins and ablated oxidative stress in Brown
Norway rats as putative mechanisms contributing to this
resistance.
In this study, we used Brown Norway and Sprague Dawley
rats, as well as primary cultures of their proximal epithelial
cells to elucidate new mechanisms underlying the resistance/
susceptibility to renal ischemia and to identify novel targets
for experimental intervention in ATN. We demonstrate that
Brown Norway rats recovered earlier after I/R, thus suggesting
Brown Norway rats as a useful experimental model to design
new therapeutic approaches for ATN resolution.
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RESULTS
Renal damage and dysfunction in Brown Norway and
Sprague Dawley rats
We performed 45 min of bilateral ischemia and 24 h of
reperfusion in male Brown Norway and Sprague Dawley rats
obtained from our own breeding facility. Renal injury is
maximal at this time point in this model.10 Sham-operated
animals were used as controls. Renal function was estimated
by urea and creatinine levels in serum. After periodic acid-
Schiff (PAS) staining of paraffin-embedded renal sections,
histological damage was scored according to the following
criteria: proximal tubule cell morphology alterations, brush
border loss, proximal tubular dilation and denudation, as
well as the presence of casts and infiltrates.
Sprague Dawley and Brown Norway rats showed similar
high urea and creatinine levels at 24 h after ischemia
(Figure 1a). Accordingly, histological examination after PAS
staining also showed patched ATN in both Sprague Dawley
and Brown Norway rats at 24 h of reperfusion (Figure 1b). In
addition, phalloidin staining of renal tissue cryosections
showed similar brush border loss and actin cytoskeleton
disorganization (Figure 1b). Histopathological scoring
confirming similar I/R injury is shown in Table 1.
To verify that this unexpected susceptibility of Brown Norway
rats was not a feature of our own colony, we also studied
Brown Norway rats obtained from two widely recognized
commercial suppliers (Harlan Laboratories Models, Boxmeer,
The Netherlands and Charles River Laboratories International,
Margate, UK) (Figure 1c). Renal function at 24 h of reperfusion
was similarly affected in Brown Norway rats from our colony
and from the other two suppliers: BN/RijHsd (Harlan Labora-
tories Models) and BN/OrlCrl (Charles River Laboratories
International). Accordingly, similar injury was observed in
PAS-stained tissue sections of Brown Norway rats obtained
from both suppliers (data not shown).
These results demonstrate that both Sprague Dawley and
Brown Norway rats develop similar acute renal injury after I/R.
Primary proximal tubule cells from both Sprague Dawley and
Brown Norway rats exhibit damage in response to hypoxia/
reoxygenation
We further analyzed the response of Sprague Dawley and
Brown Norway rats to I/R using primary cultures of their
proximal tubule cells after hypoxia/reoxygenation. We
previously demonstrated that this protocol provokes, in the
rat proximal cell line NRK-52E, cytoskeleton alterations, focal
adhesion disassembly, cell–cell adhesion impairment, and cell
shedding, all features evidenced in the I/R rat model.5
Primary cells under hypoxia/reoxygenation were stained
with phalloidin and anti-zonula occludens-1 (ZO-1) anti-
body to observe actin cytoskeleton organization and
determine cell–cell adhesion integrity, respectively. Hypoxia/
reoxygenation induced marked actin cytoskeleton disorgani-
zation and depolymerization in primary cells from both
strains. The lower signal for F-actin detectable at 3 h of
reoxygenation in both cases, indicating actin depolymeriza-
tion (Figure 2a) is noted. Cytokeratin immunostaining was
used as an epithelial marker. In addition, ZO-1 internaliza-
tion from the plasma membrane was evident early during
reoxygenation in cells from Sprague Dawley and Brown
Norway rats, indicating that in both cases, cell–cell adhesion
is similarly affected in response to hypoxia/reoxygenation
(Figure 2b).
These results demonstrate that proximal tubular cells from
Sprague Dawley and Brown Norway rats exhibit similar
injury in response to hypoxia/reoxygenation and support our
in vivo data.
Sprague Dawley and Brown Norway rats exhibit differential
intracellular signaling in response to ischemia
To analyze the renal response of both strains to ischemia, we
extended the studies up to 15 days of reperfusion when
recovery of renal function is observed in this in vivo model.10
We studied the activity of signaling pathways involved in cell
survival and proliferation, oxidative stress response, and
adaptation to hypoxia, such as the extracellular signal-
regulated kinase (ERK1/2), serine–threonine protein kinase
Akt (AKT), manganese superoxide dismutase (MnSOD), and
the hypoxia-inducible factor-1 alpha (HIF-1a) target genes:
prolyl-hydroxylase-3 (PHD-3), vascular endothelial growth
factor (VEGF), and thrombospondin-1 (TSP-1).
Western blot of total renal lysates showed clear differences
in cell signaling triggered by I/R in both strains. As shown in
Figure 3a, Brown Norway rats had a marked induction of
p-AKT at 24 h and 5 days of reperfusion. Notably, p-ERK 1/2
was markedly induced after ischemia in Brown Norway rats.
MnSOD levels were slightly higher in Brown Norway than in
Sprague Dawley rats, in the whole I/R kinetic.
Using real-time PCR, we assessed the expression of
HIF-1a target genes, namely VEGF, TSP-1, and PHD-3
(Figure 3b). Both strains showed a similar expression at 24 h,
but VEGF and PHD-3 remained higher in Brown Norway,
later in reperfusion. In contrast, TSP-1, which has been
described as a marker of renal ischemic damage,11 was higher
in Sprague Dawley rats.
Although I/R-induced injury is similar in both Brown
Norway and Sprague Dawley rats, these results indicate that
both strains exhibit a different response to ischemia and
recovery mechanisms might be differently triggered in time.
Therefore, a distinct outcome might be expected.
Brown Norway rats show faster recovery from I/R injury
Differences in gene expression and cell signaling could
account for a different outcome of ischemic injury as
suggested above. Thus, we studied renal function and kidney
structure during I/R up to 15 days after ischemia.
As presented in Figure 4, serum urea and creatinine values,
as well as creatinine clearance, normalized in both rat strains
after 5–7 days of reperfusion, consistent with reported data.10
However, the improvement in renal function measured by
serum creatinine clearance was observed earlier in Brown
Norway rats, that is, around day 3.
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This delay in renal function recovery of Sprague Dawley vs
Brown Norway rats correlated with a delay in kidney size
recovery in the Sprague Dawley strain. Indeed, the length of
the major kidney diameter was longer in Sprague Dawley rats
at the seventh day, whereas it was normal in Brown Norway






























































































Brown Norway Brown Norway
Sham IR-24h
Sham IR-24h Sham IR-24h
Sham IR-24h
Figure 1 | Sprague Dawley and Brown Norway rats exhibit similar ischemia/reperfusion-induced injury. Comparable injury is also
observed in Brown Norway rats from different origins after ischemia/reperfusion. (a) Urea and creatinine levels were estimated in serum
obtained from Sprague Dawley and Brown Norway rats after surgical procedure (sham) or after 45min of ischemia and 24 h of reperfusion
(IR 24 h). n¼ 10 animals per group. Data are presented as means±s.e.m., and statistically significant differences are indicated (*Po0.05).
(b) Left panels: PAS staining. Prominent ATN is observed in both rat strains at 24 h of reperfusion. Right panels: phalloidin staining. The
presence of apical microvilli in sham animals (arrows) and the loss of brush border in ischemia/reperfusion at 24 h condition (asterisks) are
noted. Representative images of each experimental group are shown. Original magnification  200 (left) and  400 (right). (c) Urea and
creatinine levels were estimated in serum from Brown Norway (BN) rats of different origins: our own colony (RyCajal), Harlan Laboratories
(Harlan) and Charles River Laboratories (ChRiver), in sham and ischemia/reperfusion at 24 h (n¼ 10). Data are presented as means±s.e.m. in
comparison with sham condition. No significant differences were found at 24 h among groups. ATN, acute tubular necrosis; PAS, periodic
acid-Schiff.
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Norway, 14.6±1.35 mm; I/R at day 7: Sprague Dawley,
17.1±2.7 mm and Brown Norway, 14.3±2.4 mm.
Moreover, between 5 and 7 days of reperfusion, PAS
staining showed that Sprague Dawley kidneys still exhibited
ATN, dilated tubules, thinner brush border, more evident
infiltrates, and overall more altered renal structure
(Figure 5a). Brown Norway kidneys presented a much better
preserved structure. Phalloidin staining confirmed the
improved recovery of kidney structure in Brown Norway
rats at 5–7 days, as evidenced by the well-organized brush
border. Brush border absence and collapsed actin at the cell
basement are still observed in several tubules in Sprague
Dawley rats (Figure 5b). At 15 days of reperfusion,
histopathology differences diminished, according to the
functional parameter normalization observed in both strains.
Scores for tissue damage also confirmed faster recovery in
Brown Norway rats throughout reperfusion (Table 1).
Supporting the different response, the HIF-dependent
gene TSP-1 remained elevated at 7 days in Sprague Dawley
rats, correlating with histological damage. Accordingly,
5-bromo-2-deoxyuridine (BrdU) and PCNA (proliferating
cell nuclear antigen) staining in proximal tubules were much
lower in Brown Norway rats at 5 days of reperfusion
(Figure 6 and Table 2), probably due to the fact that proximal
cells had already recovered. However, proliferation was higher
in Brown Norway rats at 24 h, suggesting earlier triggering of
recovery mechanisms in this strain.
These data demonstrate that although Sprague Dawley
and Brown Norway rats show similar I/R injury, Brown
Norway rats show faster recovery, in agreement with the
differential signaling found.
Brown Norway rats exhibit faster inflammatory response
resolution
As prominent cell infiltrates were still observed in Sprague
Dawley rats at 7 days of reperfusion, and inflammatory
response resolution affects renal recovery, using real-time PCR,
we analyzed the proinflammatory gene expression, that is, MCP-1
(monocyte chemoattractant protein-1), interleukin IL-10, TNF
(tumor necrosis factor)-a, IL-1b, INF (interferon)-g, STAT-4
and STAT-6; nuclear factor NFkB activity and very late
antigen-4/vascular cell adhesion molecule-1 (VLA-4/VCAM-1)
pathway for leukocyte infiltration, in both strains.
As presented in Figure 7a, a strong cytokine induction was
observed in reperfusion, although no marked differences
were found between strains at 24 h. However, Brown Norway
rats recovered basal levels faster. In fact, some of these genes
(MCP-1 and IL-1b) still remained elevated at 7 days of
reperfusion in Sprague Dawley rats. STAT-4 and STAT-6 were
higher in Sprague Dawley rats but they were not altered
significantly in Brown Norway. Moreover, NFkB activation
was shorter in nuclear extracts of Brown Norway rat kidneys,
as shown in Figure 7b.
Immunostaining for macrophages (CD68) and T lym-
phocytes (T-cell marker) in renal tissues obtained from
Sprague Dawley and Brown Norway rats were performed to
quantify cell infiltrates. Results in Figure 8c show similar
macrophage infiltration in Sprague Dawley and Brown
Norway rats at 24 h of reperfusion, although the number of
T cells is significantly higher in Brown Norway. Both
infiltrating cell populations diminished earlier in Brown
Norway rats, in agreement with cytokine expression results
and lesser infiltrates in PAS staining in comparison with
Sprague Dawley, at 7 days of reperfusion.
Thus, to analyze leukocyte activation, we measured, by flow
cytometry, VLA-4 expression in peripheral blood leukocytes
(PBLs) from both rat strains. As presented in Figure 8a, VLA-4
expression was similar in PBLs from Sprague Dawley and
Brown Norway rats at 24 h of reperfusion, although this
expression was reduced faster in Brown Norway. Accordingly,
VCAM-1 expression in total kidney lysates was higher and
maintained in Sprague Dawley rats (Figure 8b).
Together, these results suggest a shorter proinflammatory
response in Brown Norway rats during I/R that may lead to
the accelerated recovery exhibited by this strain.
DISCUSSION
Identification of mechanisms to accelerate recovery after
I/R damage could be critical to reduce morbidity and
mortality of some clinical situations, such as renal transplant
or acute renal failure. The use of experimental animal
models with different susceptibility to ischemic damage
could shed light on this issue. In this study, we report
the different outcomes after I/R in two rat strains, Brown
Norway and Sprague Dawley. Both develop similar
damage after I/R, but Brown Norway rats recover faster. A
different regulation of signaling mechanisms and a faster
resolution of inflammatory response contributes to this
better recovery.
Recently, the resistance of Brown Norway rats to renal
ischemia was described.8,9 In contrast, Sprague Dawley
rats have been extensively reported as a strain susceptible
to develop renal ischemic injury. With the aim to







SD IR-24h 2.86±0.14 2.57±0.30 1.43±0.20
BN IR-24h 2.91±0.01 2.73±0.03 1.91±0.03
SD IR-3d 2.55±0.35 2.47±0.60 3.25±0.02
BN IR-3d 2.05±0.26 2.07±0.43 2.80±0.04*
SD IR-5d 2.46±0.3 2.00±0.35 2.14±0.24
BN IR-5d 1.95±0.28* 2.50±0.50 1.76±0.12
SD IR-7d 2.55±0.25 2.05±0.50 1.97±0.07
BN IR-7d 1.86±0.3* 1.56±0.35 1.14±0.24*
SD IR-15d 0.96±0.21 0.31±0.17 0.73±0.09
BN IR-15d 0.55±0.07* 0.04±0.02* 0.25±0.04*
Abbreviations: ATN, acute tubular necrosis; BN, Brown Norway; IR, ischemia–reperfu-
sion; SD, Sprague Dawley.
Scoring indicates similar ATN development in SD and BN rats at 24 h of reperfusion,
but accelerated ATN recovery in BN rats during reperfusion (IR-3, IR-5, IR-7, and IR-15
days). Data are expressed as means±s.e.m. Scoring criteria are described in the
‘Materials and methods’ section. Statistically significant differences were found in
comparison with SD values (*Po0.05).
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unveil mechanisms responsible for this ischemia-resistant
phenotype, in this study, we compared Sprague Dawley and
Brown Norway responses with renal ischemia. Surprisingly,
our results did not agree with those of earlier studies,8 as we
found similar renal dysfunction and histopathological
damage at 24 h of reperfusion, suggesting that Brown Norway
rats were not resistant to I/R.
To ascertain whether the genetic background in our colony
could be responsible for the Brown Norway susceptibility
described in this study, Brown Norway rats from commercial
suppliers Harlan and Charles River were also included in the
study. These animals exhibited similar renal damage after I/R
to our colony, thus confirming that the Brown Norway
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Figure 2 |Primary cultures of proximal tubule cells from Sprague Dawley and Brown Norway rats exhibit similar damage in
response to hypoxia/reoxygenation. (a) F-actin organization visualized by phalloidin staining (red). The reduction in F-actin signal during
hypoxia/reoxygenation (H/R), indicating actin depolymerization, is observed similarly in both rat strains. Immunostaining for cytokeratin
(green) was used as an epithelial marker. (b) ZO-1 localization observed by immunofluorescence. The disruption of ZO-1 immunostaining
along the membrane during hypoxia/reoxygenation (arrows) is noted. Original magnification:  400. Representative images of three
independent experiments are shown. ZO-1, zonula occludens-1.
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case, the uncharacterized degree of genetic variation remain-
ing in an inbred population and the husbandry alterations
between institutions should be taken into account when
comparing results obtained from different laboratories.
Similar damage after I/R was also shown using primary
proximal tubule cells in an in vitro model of hypoxia/
reoxygenation, which reproduces I/R stimuli in vivo.5 No
differences were found in primary cultures from both strains
regarding cytoskeleton disorganization, ZO-1, and E-cadher-
in redistribution (data not shown), indicating that proximal
tubular cells of both strains are equally affected by ischemia,
and supporting the in vivo results.
In spite of the similar renal damage observed, marked
differences in the renal tissue response to ischemia were
exhibited. This fact could be related to the different I/R
outcomes reported in this study. ERK1/2 and AKT were
differently activated in Brown Norway rats. Some studies
have related them to a better response after renal ischemia by
inducing cell adhesion or increased survival.12–14 Moreover,
ERK1/2 and AKT activation is involved in proximal tubule
repair after ATN.15,16 Consequently, stronger AKT activation
and earlier ERK1/2 induction in Brown Norway rats at 24 h
might promote tubular cells proliferation, as the increase in
BrdU incorporation and PCNA staining indicate. Thus, the
triggering of repair mechanisms as soon as at 24 h of
reperfusion could contribute to the fast recovery exhibited by
Brown Norway rats later during reperfusion. Moreover,
proximal tubule cell proliferation is delayed in Sprague
Dawley rats, in accordance with the delay in renal recovery.
Related to survival, high levels of MnSOD have been
detected in Brown Norway rats that could ameliorate reactive
oxygen species-induced damage,9 as reactive oxygen species
have been proposed as important mediator of renal damage
during reperfusion.17 Indeed, exogenous administration of
SOD mimetics improves tubular damage after I/R in vivo18
and hypoxia/reoxygenation in vitro.19 We also observed greater
induction of nitric oxide synthase 2 in Brown Norway at 24 h
of reperfusion (data not shown). The beneficial effects of nitric
oxide have been described in ischemic preconditioning in several
organs including the kidney, related to vascular tone and
permeability.20–22 Therefore, it is conceivable that a different
vascular response to I/R in both Sprague Dawley and Brown
Norway rats could contribute to the different outcome
























































































Figure 3 | Sprague Dawley and Brown Norway rats present different cell signaling and gene expression in response to ischemia/
reperfusion. (a) Expression of p-ERK1/2, MnSOD, and p-Akt in renal lysates from Sprague Dawley and Brown Norway rats during ischemia/
reperfusion (IR), estimated by western blotting. Total ERK and actin levels were used as loading control. Representative blots are shown, and
the ratios MnSOD/actin and p-Akt/actin quantification are presented. (b) mRNA expression of VEGF, TSP-1, and PHD-3 was determined
by qRT-PCR. Statistically significant differences were found in comparison with Sprague Dawley values (*Po0.05). MnSOD, manganese
superoxide dismutase; p-ERK1/2, phospho-extracellular signal-regulated kinase-1/2; PHD-3, prolyl-hydroxylase-3; qRT-PCR; quantitative
real-time PCR; TSP-1, thrombospondin-1; VEGF, vascular endothelial growth factor.
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In addition, differences in HIF-mediated gene expression
were found between Sprague Dawley and Brown Norway rats:
VEGF, PHD-3, and TSP-1 were similarly induced in Brown
Norway and Sprague Dawley rats just after ischemia and at
24 h of reperfusion. Thereafter, from 3 to 7 days, VEGF and
PHD-3 exhibited higher expression in Brown Norway rats.
HIF-related expression has been linked to decreased tissue
damage.23–25 Accordingly, HIF-1a preconditioning reduces
I/R-induced injury.26 In our case, similar levels of HIF-target
genes after ischemia in both rats correlate with similar renal
damage at 24 h, but different expressions later in reperfusion
might contribute to the faster recovery observed in these
rats. Indeed, preliminary data of our laboratory suggest that
HIF induction during reperfusion promotes ischemic injury
recovery.27 With regard to this, VEGF has been related to
increased survival after ischemia and better long-term
prognosis in kidney allografts.28 Remarkably, TSP-1 which
is a marker for renal injury10 after I/R remains higher in
Sprague Dawley rats correlating with still impaired renal
structure and delayed recovery.
With regard to renal function, all the parameters tested
reached basal levels earlier in Brown Norway rats. Although
serum creatinine and urea levels normalized between 5 and
7 days of reperfusion in both rat strains, creatinine clearance
did not return to baseline in Sprague Dawley rats even at
15 days of reperfusion. These alterations correlated with
impaired renal structure at 7–15 days in Sprague Dawley rats.
Related to this, Basile et al.29 studied recovery after I/R in
Sprague Dawley rats after 35 days, finding that although basal
urea and creatinine levels were restored from the seventh day
onward, the kidneys had a decreased capacity to concentrate
urine and an increased susceptibility to progressive renal
disease, with interstitial fibrosis and chronic hypoxia.
I/R-induced injury is also associated with an inflamma-
tory response in renal parenchyma, which contributes to
renal repair.30 Our results indicate that similar cellular
infiltrates are observed at 24 h in both Sprague Dawley and
Brown Norway rats. In contrast, at 7 days of reperfusion,
infiltrates are more prominent in Sprague Dawley kidneys
than in Brown Norway kidneys, pointing out the fact that
both strains have different inflammatory response regulation,
which might account for the different outcomes after I/R
reported in this study. Accordingly, proinflammatory med-
iators such as MCP-1, IL-10, TNF-a, IL-1b, and IFN-g, as
well as NFkB activation diminished earlier in Brown Norway
rats. Moreover, analysis of VLA-4 expression in PBLs from
both strains and VCAM-1 expression in the renal tissue
confirmed that this leukocyte extravastion pathway is more
markedly activated in Sprague Dawley rats. The different
NFkB activation reported in this study may be accounted for
this differential outcome, as the result of differences in the
vascular response to I/R mentioned above and previously
suggested.21
In summary, our results demonstrate that even though
Brown Norway and Sprague Dawley rats exhibit similar
tubule damage after renal ischemia, they have a different
response during renal I/R. Consequently, Brown Norway rats
showed better outcome of tubular damage as they exhibited
faster inflammation resolution. In spite of the similar
susceptibility to ischemic damage, Brown Norway rats could
be recognized as an outstanding experimental model for
identification of mechanisms to potentially promote faster
ATN recovery during acute renal failure and renal transplan-
tation in humans.
MATERIALS AND METHODS
Animal model of renal I/R injury
Pathogen-free male Sprague Dawley and Brown Norway rats,
weighting 180–200 g, were obtained from our own breeding colony
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Figure 4 |Renal function parameters recover earlier in Brown
Norway rats in comparison with Sprague Dawley rats.
(a) Serum urea and creatinine levels measured during ischemia/
reperfusion (IR). (b) Creatinine clearance estimated as ml/min. All
data are presented as mean±s.e.m. (n¼ 10). Statistically
significant differences were found in comparison with Sprague
Dawley values (*Po0.05).
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Figure 5 |Brown Norway rats exhibit accelerated recovery of ischemia/reperfusion-induced renal tissue damage in comparison with
Sprague Dawley rats. (a) PAS staining of kidney sections from Sprague Dawley (SD) and Brown Norway (BN) rats during ischemia/
reperfusion (IR). The recovery of renal tissue structure in Brown Norway rats earlier than in Sprague Dawley rats is noted. At 7 days of
reperfusion, large intraluminal space and more infiltrating cells (circled) in Sprague Dawley rats are still evidenced. (b) Phalloidin staining.
The presence of apical microvilli and thick F-actin at the cell basement earlier during reperfusion in Brown Norway rats is observed. Tubules
with a loss of brush border (asterisks) and collapsed basal F-actin (arrows) are still evident in Sprague Dawley rats at 7 days. Representative
images of each experimental group are shown. Original magnifications  400. PAS, periodic acid-Schiff.
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Figure 6 |BrdU incorporation and PCNA expression in Sprague Dawley and Brown Norway rats during ischemia/reperfusion.
(a) BrdU incorporation and (b) PCNA immunostaining in Sprague Dawley (SD) and Brown Norway (BN) rats after ischemia/reperfusion (IR).
Representative images are shown. Original magnification  400. BrdU, 5-bromo-2-deoxyuridine; PCNA, proliferating cell nuclear antigen.
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constant levels of isoflavones) and water ad libitum. In addition, for
some experiments, Brown Norway rats were obtained from Harlan
Laboratories Models (BN-RijHsd) and from Charles River Laboratories
International (BN/OrlCrl). Experimental procedures were performed
according to the European Community laws (EC609) and the Spanish
guidelines (RD 1210/2005). The experimental design was approved by
the Hospital Ramo´n y Cajal Committee for Animal Ethics.
Animals were anesthetized with 2% isofluorane (Abbot
Laboratories, Madrid, Spain) and kept on a warming tap at 37 1C
during all the surgical procedures. Renal I/R injury was induced
after laparotomy by a 45 min bilateral clamping of the renal pedicles
using nontraumatic clamps, as described previously.31 Sham-
operated animals underwent the same surgical procedure without
clamping. Animals were killed at 0, 24 h, and at 3, 5, 7. or 15 days
after reperfusion. Blood and kidneys were harvested and processed
for further analysis. Urea and creatinine levels in serum were
measured by colorimetric assay in an Aeroset System (Abbot
Laboratories). For urine determinations, animals were maintained
in metabolic cages 24 h before the killing. Creatinine clearance in
24 h was calculated using the formula: Ccr¼UcrV/Scr, expressed
in ml/min, where UCr is the value for creatinine urine concentration;
V the urine volume expressed in ml/min, and SCr the creatinine
serum concentration.
For proximal tubule cell proliferation studies by BrdU
incorporation, animals were injected intraperitoneally with BrdU
(Sigma-Aldrich, Madrid, Spain) (250 mg/kg of weight) 24 h before
they were killed (n¼ 4).
PAS, immunohistochemistry, phalloidin staining, and ATN
histological scoring
Tissue was fixed in 4% phosphate-buffered formalin (pH 7.4), and
paraffin-embedded sections were stained with PAS or immunostained
with anti-BrdU (Dako, Barcelona, Spain), anti-PCNA, anti-CD68, or
anti-T-cell marker (Santa Cruz, Santa Cruz, CA, USA) as described
previously.32 Histological scoring was performed in a blinded manner
by two independent observers. Tissue sections were rated from 1 to 4
scoring morphological alterations in proximal tubule cells, brush
border loss, detached and necrotic cells in proximal tubules, as well as
the presence of intraluminal casts and infiltrating cells.
For actin cytoskeleton visualization, renal tissue was snap frozen
in Sakura Tissue-Tek Oct Compound (Sakura, Zoeterwoude, The
Netherlands) and liquid nitrogen. Sections of 4-mm thickness were air
dried and fixed in cold ethanol-ether at 20 1C for 10 min and stained
with alexa568-phalloidin (Invitrogen, Barcelona, Spain) for 30 min.
Kidney sections were examined using a Nikon Eclipse TE2000-U
inverted microscope, and images were obtained and processed
using the NIS-Elements BR Image Software (Nikon, Anstelveen,
The Netherlands).
Establishment of primary cultures of proximal tubule cells:
Inmunofluorescence and F-actin staining
Primary cultures of rat proximal cells were obtained and cultured
following the method described by Vinay et al.33 Enrichment of cell
suspension in proximal tubules was assessed by aquaporin-1 and
cytokeratine immunostaining (490%).
For immunofluorescence, cells were seeded onto coverslips coated
with collagen IV (1mg/ml) and processed as described previously5
and stained with anti-cytokeratin (Cappel, Costa Mesa, CA, USA)
and anti ZO-1 (Zymed Laboratories, Barcelona, Spain), followed by
the appropriate secondary antibodies. To visualize actin cytoskeleton,
cells were incubated with phalloidin-Alexa Fluor 568 (Invitrogen).
mRNA expression by quantitative real-time PCR
Total RNA was isolated with the TRI Reagent (Applied Biosystems,
Madrid, Spain), and 2 mg RNA was used to obtain cDNA using the
High-Capacity RetroTranscription Kit (Applied Biosystems). A volume
of 1ml of cDNA was used as template for the quantitative PCR reaction
with SYBR Green in an ABI PRISM 7000 Sequence Detector System
(Applied Biosystems). The following primers were used: Actin, forward:
CCCAGAGCAAGAGAGG, reverse: GTCCAGACGCAGGATG; 28S,
forward: CAGTACGAATACAGACCG, reverse: GGCAACAACACAT
CATCAG; MCP-1, forward: CTGCTACTCATTCACTGGC, reverse:
CTTCTGGACCCATTCCTTATTG; IL-10, forward: GCTGAAGACC
CTCTGGAT, reverse: GTGTCACGTAGGCTTCTATG; INF-g, forward:
AAGAGCCTCCTCTTGGAT, reverse: GTGCGATTCGATGACACT;
STAT-6, forward: CACTAGCCTTCTCCTCAAC, reverse: TGAGCGA
ATGGATAGGTCT; STAT-4, forward: CAAAGCCTTTGGCAAACAC,
reverse: GAGAAGGTCTGAAGGAGACT; VEGF (A), forward: TGCC
AAGTGGTCCCAG, reverse: GTGAGGTTTGATCCGC; PHD-3, forward:
GGAACCCACACGAAGT, reverse: CAGTTTTCCTAGTTAAATTCCTGA;
TSP-1, forward: AGAACACAGATCCTGGCTAC, reverse: GGCGTTCT
TGTTGCAGTC; IL-1b, forward: CACCTCTCAAGCAGAGCACAG,
reverse: GGGTTCCATGGTGAAGTCAAC; TNF-a, forward: CCAG
GAGAAAGTCAGCCTCCT, reverse: TCATACCAGGGCTTGAGCTCA.
Ct values were analyzed with the comparative Ct method normalized to
28S expression and related to sham-operated animals as reference.
Protein studies by SDS-PAGE and western blotting
The renal frozen tissue was homogenized in lysis buffer (1% Triton
X-100, 1% NP-40, 0.25% sodium deoxycholate, 1 mmol/l DTT,
protease, and phosphatase inhibitors (all from Sigma-Aldrich)), for
20 min at 4 1C. Homogenates were centrifuged, and precleared
supernatants were resolved by SDS-PAGE and transferred into
polyvinylidene fluoride membranes (Millipore, Madrid, Spain).
Membranes were processed as described previously5 and incubated
with primary antibodies: p-ERK1/2 (Thr 202/Tyr 204) (Calbiochem,
Nottingham, UK), total ERK1/2 and p-Akt (Ser 473) (Cell Signaling,
Danvers, MA, USA), and MnSOD, VCAM-1, and actin (Santa Cruz).
Appropriate horseradish peroxidase-conjugated secondary antibodies
(Dako) were used. Membranes were developed using enhanced chemi-
luminescence (Amersham Biosciences, Barcelona, Spain).
NFjB activity assay
Extraction of nuclear fractions from total renal lysates and
expression of p50/p65 expression were performed using p50/p65
Trans-AM kit (Cat. no.: 40098; Active Motive, Carlsbad, CA, USA),
Table 2 | BrdU and PCNA quantification
Sham Ischemia IR-24h IR-3d IR-5d IR-7d IR-15d
BRDU
SD 7±2.08 10±3.46 22±3 191±32 18±2.31 10±1 6±0.58
BN 6±1 12±2.52 60±4.04* 120±6.43* 12±1.15 8±2.08 6±1.53
PCNA
SD 6±3.06 4±0.58 38±8.14 112±16.26 9±2.65 8±3.06 3±1.73
BN 9±2 24±1* 60±3.51* 44±5.51* 8±2.52 4±1.73 1±0.58
Abbreviations: BN, Brown Norway; BrdU, 5-bromo-2-deoxyuridine; IR, ischemia–
reperfusion; PCNA, proliferating cell nuclear antigen; SD, Sprague Dawley.
Quantification of both BrdU and PCNA nuclear signals, in SD and BN rats during IR,
expressed as means±s.e.m. of positive nuclei in 10 fields of each condition are
shown. Statistically significant differences were found in comparison with SD values
(*Po0.05).
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following the manufacturer’s instructions. Nuclear extract from
Jurkat cells treated with Ionomycine and phorbol 12-myristate
13-acetate (PMA) and competition assays with specific wild-type
oligo and mutant oligo were used as controls for the assay.
VLA-4 expression in PBLs by flow cytometry
PBLs were obtained from rat whole-heparinized blood by ficoll
gradient (Ficoll-Hystopaque, Sigma-Aldrich). PBLs were incubated
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Figure 7 |Proinflammatory mediators expression and NFjB activity is lower in Brown Norway rats at 7 days of reperfusion. (a) Expression
of MCP-1, IL-1b, IFN-g, TNF-a, STAT-4, STAT-6 and IL-10 determined by qRT-PCR. (b) NFkB activation in nuclear extract of kidneys from
Sprague Dawley and Brown Norway rats during ischemia/reperfusion (IR) was estimated by ELISA. All data are presented as means±s.e.m.
(n¼ 5). Statistically significant differences were found in comparison with Sprague Dawley values (*Po0.05). ELISA, enzyme-linked
immunosorbent assay; IFN-g, interferon-g; IL-1b, interleukin-1b; MCP-1, monocyte chemoattractant protein-1; NFkB, nuclear factor-kB;
qRT-PCR; quantitative real-time PCR; TNF-a, tumor necrosis factor-a.
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Figure 8 |VLA-4/VCAM-1 leukocyte extravasation pathway is less activated in Brown Norway rats. (a) Very late antigen-4 (VLA-4)
expression in peripheral blood leukocytes (PBLs) from Sprague Dawley (SD) and Brown Norway (BN) rats during ischemia/reperfusion (IR)
estimated by flow cytometry. Representative histograms are presented. (b) Representative immunoblot of vascular cell adhesion molecule-1
(VCAM-1) expression in renal tissue from Sprague Dawley and Brown Norway rats during IR. Actin expression was used as loading control
and the ratio VCAM/actin quantification is shown. (c) Quantification of CD68 and T-cell marker estimated by immunohistochemistry in renal
tissue from Sprague Dawley and Brown Norway rats. Data are expressed as means±s.e.m. of positive nuclei in 10 fields of each condition.
Statistically significant differences were found in comparison with Sprague Dawley values (*Po0.05).
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After washing, cells were incubated with goat anti-mouse fluorescein
isothiocyanate-conjugated antibody (Jackson ImmunoResearch, Bar
Harbor, ME, USA) at 4 1C for 45 min. PBLs incubated only with the
secondary antibody were used as a negative control for nonspecific
antibody binding. The samples were analyzed using FACScan
cytometer (Becton Dickinson, Oxford, UK).
Statistical analysis
Data are presented as mean±s.e.m. After the Levene test of
homogeneity of variance, the Kruskal–Wallis test was used for
group comparison. Po0.05 was considered significant. In case of
significant differences, intergroup differences were analyzed by
post hoc Mann–Whitney U-tests with the Bonferroni correction.
Statistical analysis was carried out using Statistical Package for
the Social Sciences (SPSS, SPSS, Madrid, Spain) version 11.0.
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